In this review, we evaluate the role of viral and host genetics in the natural history and treatment outcomes of chronic HCV infection, and consider how this knowledge might help individualize clinical management in the era of DAA therapy.
|Pages (from-to)||413 - 427|
|Number of pages||15|
|Journal||Best Practice & Research: Clinical Gastroenterology|
|Publication status||Published - 2012|